Phase II study of lonidamine in metastatic prostatic carcinoma.
Stewart
D J
DJ
Ontario Cancer Treatment and Research Foundation Ottawa Regional Cancer Center, Canada.
Aitken
S E
SE
Irvine
A H
AH
Moors
D E
DE
Futter
N G
NG
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007191:Indazoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007191:Indazoles; C016371:lonidamine